{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:17:09Z","timestamp":1775009829321,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008983","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000}}],"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cryptococcal meningitis (CCM) remains one of the leading causes of mortality among HIV infected patients. Due to factors such as the severity of CCM pathology, the quality of life (QOL) of patients post-treatment is likely to be poor. Few studies have reported on QOL of CCM patients post treatment completion. We used data collected among patients in the CryptoDex trial (ISRCTN59144167) to determine QOL and associated factors at week 10 and six months from treatment initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>CryptoDex was a double-blind placebo-controlled trial of adjunctive dexamethasone in HIV infected adults with CCM, conducted between 2013 and 2015 in six countries in Asia and Africa. QOL was determined using the descriptive and Visual Analog Scales (VAS) of the EuroQol Five-Dimension-Three-Level (EQ-5D-3L) tool. We derived index scores, and described these and the VAS scores at 10 weeks and 6 months; and used linear regression to determine the relationship between various characteristics and VAS scores at both time points. VAS scores were interpreted as very good (81\u2013100), good (51\u201380), normal (31\u201350) and bad\/very bad (0\u201330).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 451 patients enrolled in the trial, 238 had QOL evaluations at week 10. At baseline, their mean age (SD) was 35.2(8.5) years. The mean index scores (SD) were 0.785(0.2) and 0.619(0.4) among African and Asian patients respectively at week 10, and 0.879(0.2) and 0.731(0.4) among African and Asian patients respectively at month six. The overall mean VAS score (SD) at 10 weeks was 57.2 (29.7), increasing significantly to 72(27.4) at month six (p&lt;0.001). At week 10, higher VAS score was associated with greater weight (p = 0.007) and being African (p&lt;0.001), while lower VAS score was associated with positive yeast culture at day 14 (p = 0.026). At month six, higher VAS score remained associated with African origin (p = 0.006) while lower VAS score was associated with positive yeast culture (p = 0.006). Lower VAS scores were associated with higher number of inpatient days at 10 weeks and 6 months (p = 0.003 and 0.002 respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>QOL was good among patients that had completed therapy for CCM, but below perfect. Strategies to improve QOL among CCM survivors are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0008983","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T14:43:49Z","timestamp":1614782629000},"page":"e0008983","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-4037","authenticated-orcid":true,"given":"Jonathan","family":"Kitonsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9442-1719","authenticated-orcid":true,"given":"Julius","family":"Kiwanuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-5515","authenticated-orcid":true,"given":"Zacchaeus","family":"Anywaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-1501","authenticated-orcid":true,"given":"Sheila","family":"Kansiime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6726-740X","authenticated-orcid":true,"given":"Kenneth","family":"Katumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-7394","authenticated-orcid":true,"given":"Namirembe","family":"Aeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1978-1559","authenticated-orcid":true,"given":"Justin","family":"Beardsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddie","family":"Kibengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0239-7278","authenticated-orcid":true,"given":"Alastair","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-6280","authenticated-orcid":true,"given":"Jeremy","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"issue":"4","key":"pntd.0008983.ref001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial","volume":"14","author":"B Grinsztejn","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"4","key":"pntd.0008983.ref002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"AIDS (London, England)"},{"issue":"8","key":"pntd.0008983.ref003","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"R Rajasingham","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"pntd.0008983.ref004","doi-asserted-by":"crossref","first-page":"e0210287","DOI":"10.1371\/journal.pone.0210287","article-title":"Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda","volume":"14","author":"J Kitonsa","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"pntd.0008983.ref005","doi-asserted-by":"crossref","first-page":"e0126810","DOI":"10.1371\/journal.pone.0126810","article-title":"Factors That Affect Quality of Life among People Living with HIV Attending an Urban Clinic in Uganda: A Cohort Study","volume":"10","author":"D Mutabazi-Mwesigire","year":"2015","journal-title":"PLOS ONE"},{"issue":"4","key":"pntd.0008983.ref006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-155-4-201108160-00358","article-title":"Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda","volume":"155","author":"EJ Mills","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"23","key":"pntd.0008983.ref007","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1001\/jama.288.23.3027","article-title":"Health-Related Quality-of-Life Assessments and Patient-Physician CommunicationA Randomized Controlled Trial","volume":"288","author":"SB Detmar","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"pntd.0008983.ref008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2049-3258-72-40","article-title":"What determines health-related quality of life among people living with HIV: an updated review of the literature","volume":"72","author":"S Degroote","year":"2014","journal-title":"Archives of Public Health"},{"key":"pntd.0008983.ref009","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1745-6215-15-441","article-title":"CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial","volume":"15","author":"J Day","year":"2014","journal-title":"Trials"},{"issue":"6","key":"pntd.0008983.ref010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis","volume":"374","author":"J Beardsley","year":"2016","journal-title":"The New England journal of medicine"},{"issue":"1","key":"pntd.0008983.ref011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1745-6215-15-441","article-title":"CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial","volume":"15","author":"J Day","year":"2014","journal-title":"Trials"},{"key":"pntd.0008983.ref012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S38850","article-title":"Cryptococcal meningitis: epidemiology and therapeutic options","volume":"6","author":"DJ Sloan","year":"2014","journal-title":"Clinical Epidemiology"},{"key":"pntd.0008983.ref013","unstructured":"EuroQol. EoroQol Research Foundation. EQ-5D-3L User Guide 2018."},{"key":"pntd.0008983.ref014","unstructured":"WHOQOL. Measuring Quality of Life. 1997 [cited 2019 10 June]. Available from: https:\/\/www.who.int\/healthinfo\/survey\/whoqol-qualityoflife\/en\/."},{"key":"pntd.0008983.ref015","volume-title":"Estimating Population-Based Values for EQ-5D Health States in Thailand","author":"JC Sirinart Tongsiri","year":"2011"},{"key":"pntd.0008983.ref016","article-title":"How do Zimbabweans value health states?","author":"KH Jennifer Jelsma","year":"2003","journal-title":"BioMed Central"},{"issue":"194","key":"pntd.0008983.ref017","article-title":"Assessment of quality of life using the EQ-5D-3L instrument for hospitalised patients with femoral fracture in Brazil","volume":"16","author":"Ivanise Arouche Gomes de Souza CCdAP, Andrea Liborio Monteiro","year":"2018","journal-title":"BMC"},{"key":"pntd.0008983.ref018","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40588-016-0035-5","article-title":"HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings","volume":"3","author":"MW Tenforde","year":"2016","journal-title":"Curr Clin Microbiol Rep"},{"issue":"743","key":"pntd.0008983.ref019","article-title":"Recent advances in managing HIV-associated cryptococcal meningitis [version 1; peer review: 2 approved]","volume":"8","author":"T Boyer-Chammard","year":"2019","journal-title":"F1000Research"},{"issue":"14","key":"pntd.0008983.ref020","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination Antifungal Therapy for Cryptococcal Meningitis","volume":"368","author":"JN Day","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pntd.0008983.ref021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1497.2005.30402.x","article-title":"The Association of Health-related Quality of Life with Survival Among Persons with HIV Infection in the United States","volume":"20","author":"WE Cunningham","year":"2005","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"pntd.0008983.ref022","article-title":",,Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the gastor-oesophageal junction","volume":"44","author":"JD Philippe Nafteux","year":"2013","journal-title":"Eurpean Journal of Cardio-Thoracic Surgery"},{"issue":"4","key":"pntd.0008983.ref023","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/jinf.2001.0916","article-title":"A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B","volume":"43","author":"P Pitisuttithum","year":"2001","journal-title":"The Journal of infection"},{"issue":"5","key":"pntd.0008983.ref024","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes","volume":"58","author":"JN Jarvis","year":"2014","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"11","key":"pntd.0008983.ref025","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy","volume":"46","author":"A Kambugu","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"pntd.0008983.ref026","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/515074","article-title":"Early Mycological Treatment Failure in AIDS-Associated Cryptococcal Meningitis","volume":"28","author":"PA Robinson","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"pntd.0008983.ref027","doi-asserted-by":"crossref","first-page":"ofv157","DOI":"10.1093\/ofid\/ofv157","article-title":"Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis","volume":"2","author":"MA Rolfes","year":"2015","journal-title":"Open forum infectious diseases"},{"key":"pntd.0008983.ref028","article-title":"Factors That Affect Quality of Life among People Living with HIV Attending an Urban Clinic in Uganda: A Cohort Study","author":"KA Mutabazi-Mwesigire D","year":"2015","journal-title":"PLoS ONE"},{"key":"pntd.0008983.ref029","unstructured":"WHO. Health statistics and information systems: Measuring quality of life. 2020."},{"key":"pntd.0008983.ref030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa","volume":"378","author":"F Sile","year":"2018","journal-title":"The New England journal of medicine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008983","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T13:42:28Z","timestamp":1615815748000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008983"}},"subtitle":[],"editor":[{"given":"Nelesh Premapragasan","family":"Govender","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008983","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.19.20135368","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]}}}